Product record
Ayurvedic medicines that failed state lab tests: Maharashtra FDA table
Last checked 10 October 2026
Maharashtra FDA's table, as of 9 Oct 2026, lists ten Inducare Pharma products and Divya Pharmacy's Arjuna Kwath as not of standard quality for fungus, microbial limits or description; each row is a finding on a tested sample, not a ban.
- Classification
- Declared Not of Standard Quality (NSQ)
- Decided by
- Maharashtra Food and Drug Administration
- Reference
- Maharashtra FDA NSQ alerts table, 190 rows as of 9 Oct 2026, about 20 for ayurvedic, siddha and unani products
- Latest action
- 9 October 2026
- Last checked
- 10 October 2026
Photo: Ayurvedic herbs 02.jpg by Vis M (CC BY-SA 4.0). All photo credits.
Maharashtra FDA: not of standard quality (NSQ) alerts table
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Inducare Pharma (spelt Induscare in the table)
- Arogyavardhini, Sinhanad Guggul, Punarnavadi Mandur, Triphala Guggul, Kanchanar Guggul, Hingvashtak Churna, Triphala Churna, Tribhuvankirti, Shwasakuthar, Sootshekhar
- Reasons for Inducare rows
- Fungus, microbial and 'description'
- Divya Pharmacy
- Arjuna Kwath: microbial limit
- Table size
- 190 rows as of 9 Oct 2026, about 20 of them ayurvedic, siddha or unani
Maharashtra FDA publishes its failed lab tests in a table of products declared not of standard quality. As read on 9 Oct 2026 it had 190 rows, about 20 of them for ayurvedic, siddha and unani products.
The named ayurvedic rows include ten products of Inducare Pharma, which the table spells Induscare: Arogyavardhini, Sinhanad Guggul, Punarnavadi Mandur, Triphala Guggul, Kanchanar Guggul, Hingvashtak Churna, Triphala Churna, Tribhuvankirti, Shwasakuthar and Sootshekhar. The reasons given are fungus, microbial findings and description. The firm's licence was cancelled on 8 Aug 2026. A Divya Pharmacy product, Arjuna Kwath, is listed for microbial limit.
Each row is a finding on a tested sample. It is not a ban, and it is not a finding about every product of the brand. Products sold as ayurvedic that contained undeclared drugs are on a separate page.
What this means for you
A failed sample is not a ban
'Not of standard quality' is the regulator's term for a failed lab test. It concerns the tested sample and gives the state grounds to act; it does not ban the product.
The brand is not the sample
One product of a brand failing a test does not mean the brand's other products failed.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Common questions
What does 'not of standard quality' mean?
The sample failed a government lab test. The reasons here are fungus, microbial limit and description.
Official sources and primary records
- Maharashtra FDA: not of standard quality (NSQ) alerts tableRegulatorMaharashtra Food and Drug Administration · 9 October 2026
- Pune ayurvedic medicine: fungus, insects, larvae found; FDA cancels licenceNewsThe Bridge Chronicle